An activity-based cost accounting model of melanoma care was used to identify key cost drivers and opportunities for stakeholder innovation.
Alexa Boer Kimball, MD, MPH
Advertisement
Articles by Alexa Boer Kimball, MD, MPH
Advertisement
Latest Updated Articles
- Malignant Melanoma: The Implications of Cost for Stakeholder Innovation
Published: April 4th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
Medetomidine: The Demon in the Illicit Fentanyl Supply
5
